MAP3K13 anticorps (AA 52-305)

N° du produit ABIN7875559

Cet anticorps anti-MAP3K13 Monoclonal Souris (Clone 810CT26-6-1-1) (ABIN7875559) détecte spécifiquement MAP3K13 dans WB et IF. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour MAP3K13 anticorps (AA 52-305) (ABIN7875559)

Antigène: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp MAP3K13 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF)

Clone: 810CT26-6-1-1

Détail du produit anti-MAP3K13 anticorps

Épitope: AA 52-305

Fonction: MAP3K13 Antibody

Purification: Purified

Immunogène: A portion of amino acids 52-305 from the human protein was used as the immunogen for the MAP3K13 antibody.

Isotype: IgM

Information d'application

Indications d'application: The stated application concentrations are suggested starting points. Titration of the MAP3K13 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the MAP3K13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur MAP3K13

Antigène: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Autre désignation: MAP3K13

Sujet: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.

UniProt: O43283

Pathways: Signaling Events mediated by VEGFR1 and VEGFR2